Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer

The silencing of thyroid-related genes presents difficulties in radioiodine therapy for anaplastic thyroid cancers (ATCs). Tunicamycin (TM), an N-linked glycosylation inhibitor, is an anticancer drug. Herein, we investigated TM-induced restoration of responsiveness to radioiodine therapy in radioiod...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yoon Ju, Lee, Jae-Eon, Ji, Hyun Dong, Lee, Bo-Ra, Lee, Sang Bong, Kim, Kil Soo, Lee, In-Kyu, Chin, Jungwook, Cho, Sung Jin, Lee, Jaetae, Lee, Sang-Woo, Ha, Jeoung-Hee, Jeon, Yong Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865976/
https://www.ncbi.nlm.nih.gov/pubmed/33499100
http://dx.doi.org/10.3390/ijms22031077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865976/
https://www.ncbi.nlm.nih.gov/pubmed/33499100
http://dx.doi.org/10.3390/ijms22031077

Ejemplares similares